Commentary: Pharm Biotechnol Curr Res (1-2)
Chemotherapies Is Automatically Selected For the Phase 3 Confirmatory Trial in Oncology
Author(s): Ticole Li
DOI: 10.36648/ippbcr.7.2.151
Prior to Considering Therapeutic Interventions for Mutant Strains of SARS-Cov-2
Author(s): Phen Luo
DOI: 10.36648/ippbcr.7.2.152
Commentary: Pharm Biotechnol Curr Res (1-2)
Anti-Cancer Drug and the Associated Toxicity
Author(s): Celebioglu Ahah
DOI: 10.36648/ippbcr.7.2.153
Perspective Article: Pharm Biotechnol Curr Res (1-2)
Human Genome Opens the Better Approach to Concentrate on Sickness Quality
Author(s): Ingshi Maily
DOI: 10.36648/ippbcr.7.2.154
Opinion Article: Pharm Biotechnol Curr Res (1-2)
Nanotechnology Applications for Effective Drug Delivery
Author(s): Brahimzadeh Ingye
DOI: 10.36648/ippbcr.7.2.155
Commentary: Pharm Biotechnol Curr Res (1-2)
Nano capsule Is Made of a Polymeric Layer
Author(s): Rahimzadeh Engye
DOI: 10.36648/ippbcr.7.2.156
Commentary: Pharm Biotechnol Curr Res (1-2)
Organic Entities and Abiotic Materials
Author(s): Michael Jutler
DOI: 10.36648/ippbcr.7.2.157
Perspective Article: Pharm Biotechnol Curr Res (1-2)
Recombinant Viral Vectors Created For Quality Exchange Treatment
Author(s): Alara Jaff
DOI: 10.36648/ippbcr.7.2.158
Perspective Article: Pharm Biotechnol Curr Res (1-2)
Indicative Biomarker and Remedial Objective for Bladder Disease
Author(s): Riccarda Antio
DOI: 10.36648/ippbcr.7.2.159
Opinion Article: Pharm Biotechnol Curr Res (1-2)
Spectrometry Lipidomics are Giving New Chances to Figure out Lipid Kinase Movement
Author(s): Huang Lin
DOI: 10.36648/ippbcr.7.2.160
Review Article: Pharm Biotechnol Curr Res
Author(s): Great Ijomah*
Pharmaceutical Biotechnology: Current Research received 45 citations as per Google Scholar report